Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (1-10 of 323) with videos related to

Pageof 33
Sort By:
Der Urologe. Ausg. A|August 14, 2020
[Olaparib for metastatic prostate cancer-the PROfound trial]Axel S Merseburger
Aktuelle Urologie|August 29, 2024
Axel S Merseburger
Aktuelle Urologie|November 27, 2019
Axel S Merseburger
The Journal of Urology|August 18, 2009
Editorial commentAxel S Merseburger
Aktuelle Urologie|February 5, 2020
Axel S Merseburger
Aktuelle Urologie|July 30, 2020
Axel S Merseburger
Urologie (Heidelberg, Germany)|January 21, 2025
[Treatment algorithm following first-line therapy failure in metastatic prostate cancer]Christian Thomas, Axel S Merseburger
Aktuelle Urologie|August 26, 2025
Axel S Merseburger, Angelika Borkowetz
Oncotargets and Therapy|July 13, 2012
Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatmentViktor Grünwald, Axel S Merseburger
Aktuelle Urologie|November 25, 2025
Angelika Borkowetz, Axel S Merseburger
Pageof 33

Showing results (1-10 of 323) with videos related to

Sort By:
Pageof 33
Der Urologe. Ausg. A|August 14, 2020
[Olaparib for metastatic prostate cancer-the PROfound trial]Axel S Merseburger
Aktuelle Urologie|August 29, 2024
Axel S Merseburger
Aktuelle Urologie|November 27, 2019
Axel S Merseburger
The Journal of Urology|August 18, 2009
Editorial commentAxel S Merseburger
Aktuelle Urologie|February 5, 2020
Axel S Merseburger
Aktuelle Urologie|July 30, 2020
Axel S Merseburger
Urologie (Heidelberg, Germany)|January 21, 2025
[Treatment algorithm following first-line therapy failure in metastatic prostate cancer]Christian Thomas, Axel S Merseburger
Aktuelle Urologie|August 26, 2025
Axel S Merseburger, Angelika Borkowetz
Oncotargets and Therapy|July 13, 2012
Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatmentViktor Grünwald, Axel S Merseburger
Aktuelle Urologie|November 25, 2025
Angelika Borkowetz, Axel S Merseburger
Pageof 33